Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Laskey

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
JACC. Cardiovascular Interventions|February 13, 2009
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic RegistrySuresh R Mulukutla, Helen A Vlachos, Oscar C Marroquin, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic RegistryWilliam M Wolf, Helen A Vlachos, Oscar C Marroquin, et al.
Journal of the American Heart Association|February 5, 2019
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart FailureNancy Luo, Steven J Lippmann, Robert J Mentz, et al.
American Heart Journal|June 15, 2018
Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failureNancy Luo, Nicholas G Ballew, Emily C O'Brien, et al.
JAMA Cardiology|November 18, 2019
Patient Perceptions and Familiarity With Medical Therapy for Heart FailureMarc D Samsky, Li Lin, Stephen J Greene, et al.
JACC. Heart Failure|April 1, 2017
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)Nancy Luo, Gregg C Fonarow, Steven J Lippmann, et al.
Journal of the American College of Cardiology|June 9, 2018
Home-Time After Discharge Among Patients Hospitalized With Heart FailureStephen J Greene, Emily C O'Brien, Robert J Mentz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular proceduresMarc J Schweiger, Charles E Chambers, Charles J Davidson, et al.
The American Journal of Cardiology|September 6, 2011
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Sandy M Green, Faith Selzer, Suresh R Mulukutla, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
JACC. Cardiovascular Interventions|February 13, 2009
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic RegistrySuresh R Mulukutla, Helen A Vlachos, Oscar C Marroquin, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic RegistryWilliam M Wolf, Helen A Vlachos, Oscar C Marroquin, et al.
Journal of the American Heart Association|February 5, 2019
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart FailureNancy Luo, Steven J Lippmann, Robert J Mentz, et al.
American Heart Journal|June 15, 2018
Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failureNancy Luo, Nicholas G Ballew, Emily C O'Brien, et al.
JAMA Cardiology|November 18, 2019
Patient Perceptions and Familiarity With Medical Therapy for Heart FailureMarc D Samsky, Li Lin, Stephen J Greene, et al.
JACC. Heart Failure|April 1, 2017
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)Nancy Luo, Gregg C Fonarow, Steven J Lippmann, et al.
Journal of the American College of Cardiology|June 9, 2018
Home-Time After Discharge Among Patients Hospitalized With Heart FailureStephen J Greene, Emily C O'Brien, Robert J Mentz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular proceduresMarc J Schweiger, Charles E Chambers, Charles J Davidson, et al.
The American Journal of Cardiology|September 6, 2011
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Sandy M Green, Faith Selzer, Suresh R Mulukutla, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
Pageof 14